Dental
Aspirus Stevens Point Hospital & Clinics, INC.
Aspirus Stevens Point Hospital & Clinics, INC. was paid $15.59M by Medicaid between Jan 2018 and Dec 2024, across 369 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 7.8% of everything it billed.
33Billing provider infoASPIRUS STEVENS POINT HOSPITAL & CLINICS, INC.
STEVENS POINT, WI 54481
STEVENS POINT, WI 54481
33aNPI1538112230assigned 05/17/2006
33bProvider typeGeneral Practice Dentistry
28Total paid$15.59M
24GClaims823,578
24DCodes billed369
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Dentistry providers in Wisconsin
Rank by total paid#2 of 208
Median peer was paid$26K
This provider vs. median601×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 134,841 | $2.54M | |
| 2019 | 137,004 | $2.34M | |
| 2020 | 123,212 | $2.14M | |
| 2021 | 142,884 | $2.71M | |
| 2022 | 98,275 | $1.93M | |
| 2023 | 101,901 | $2.00M | |
| 2024incomplete | 85,461 | $1.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.8% | 30,799 | 27,243 | $1.22M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.4% | 9,000 | 6,772 | $1000K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.5% | 11,295 | 9,768 | $861K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.4% | 25,491 | 22,762 | $846K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.0% | 19,263 | 16,825 | $780K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.8% | 16,469 | 13,746 | $590K |
| 80053 | Comprehensive metabolic panel | 3.6% | 32,670 | 25,102 | $568K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.2% | 11,441 | 10,277 | $497K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.5% | 6,569 | 5,777 | $392K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 6,129 | 3,924 | $356K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.1% | 2,869 | 2,614 | $323K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 5,171 | 4,653 | $293K |
357 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 2,969 | $281K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 3,948 | $238K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 6,976 | $230K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 3,833 | $228K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 6,929 | $220K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 7,494 | $210K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 2,814 | $206K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 32,430 | $192K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 12,886 | $182K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 33,289 | $181K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 11,815 | $163K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,241 | $152K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,601 | $147K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 6,174 | $146K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 4,570 | $140K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,638 | $136K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,207 | $129K |
| 80061 | Lipid panel | <1% | 10,002 | $125K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,991 | $120K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,121 | $117K |
| 80306 | <1% | 7,718 | $116K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,610 | $115K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,849 | $106K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 5,142 | $104K |
| 87632 | <1% | 566 | $100K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,018 | $97K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,575 | $93K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,127 | $92K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,240 | $87K |
| 81001 | <1% | 14,046 | $86K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,474 | $85K |
| 85610 | <1% | 6,819 | $84K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 401 | $71K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,876 | $70K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,290 | $69K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,825 | $68K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 8,038 | $65K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 5,497 | $64K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,191 | $64K |
| 87070 | <1% | 3,728 | $61K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,022 | $56K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,551 | $55K |
| 85027 | <1% | 9,571 | $54K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 285 | $51K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 718 | $49K |
| 82728 | <1% | 3,861 | $47K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 764 | $46K |
| 84484 | <1% | 6,655 | $45K | |
| 83880 | <1% | 2,252 | $44K | |
| 84703 | <1% | 5,183 | $44K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 735 | $43K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 4,224 | $42K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,361 | $42K |
| 87077 | <1% | 5,383 | $42K | |
| 82607 | <1% | 2,996 | $41K | |
| 81025 | <1% | 2,710 | $40K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 540 | $39K |
| 83690 | <1% | 7,157 | $38K | |
| 11721 | <1% | 3,434 | $37K | |
| 84702 | <1% | 1,499 | $37K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,866 | $36K |
| 87088 | <1% | 4,714 | $35K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,479 | $34K |
| 86803 | <1% | 2,480 | $33K | |
| 87186 | <1% | 4,370 | $33K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,022 | $32K |
| 87210 | <1% | 3,033 | $32K | |
| 83655 | <1% | 1,370 | $31K | |
| 29581 | <1% | 2,464 | $31K | |
| 81003 | <1% | 4,359 | $31K | |
| 87800 | <1% | 1,074 | $31K | |
| 88141 | <1% | 1,768 | $30K | |
| 84439 | <1% | 3,151 | $30K | |
| 84145 | <1% | 2,256 | $29K | |
| 11043 | <1% | 597 | $29K | |
| 83605 | <1% | 4,256 | $28K | |
| 86618 | <1% | 1,603 | $28K | |
| 76830 | Ultrasound, transvaginal | <1% | 645 | $28K |
| 84153 | <1% | 1,426 | $27K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,422 | $27K |
| 83735 | <1% | 6,491 | $26K | |
| 86850 | <1% | 2,062 | $26K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 633 | $25K |
| 86140 | <1% | 4,996 | $25K | |
| 83540 | <1% | 3,707 | $24K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 74 | $23K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,157 | $23K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 412 | $23K |
| 87506 | <1% | 143 | $23K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 537 | $22K |
| 87340 | <1% | 2,448 | $22K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 378 | $21K |
| 3008F | <1% | 2,275 | $21K | |
| 82947 | <1% | 2,352 | $21K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 335 | $21K |
| 83550 | <1% | 2,598 | $19K | |
| 86703 | <1% | 1,206 | $18K | |
| 92015 | Determination of refractive state | <1% | 2,898 | $17K |
| 82043 | <1% | 2,103 | $17K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,460 | $17K |
| 80050 | General health panel | <1% | 1,408 | $17K |
| 87631 | <1% | 176 | $17K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 278 | $16K |
| 88342 | <1% | 1,170 | $16K | |
| G0378 | Hospital observation service, per hour | <1% | 1,454 | $16K |
| 15002 | <1% | 310 | $15K | |
| 85379 | <1% | 2,242 | $15K | |
| 86780 | <1% | 1,769 | $15K | |
| 86762 | <1% | 1,176 | $15K | |
| 87081 | <1% | 1,697 | $15K | |
| 87427 | <1% | 1,300 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,628 | $13K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 596 | $13K |
| V5266 | Battery for use in hearing device | <1% | 1,208 | $12K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 307 | $12K |
| 99336 | <1% | 619 | $12K | |
| 80076 | <1% | 1,206 | $12K | |
| 82746 | <1% | 1,031 | $12K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 145 | $11K |
| 88307 | <1% | 239 | $10K | |
| 87328 | <1% | 852 | $10K | |
| 82150 | <1% | 1,625 | $10K | |
| 82950 | <1% | 838 | $10K | |
| 84481 | <1% | 754 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,737 | $10K |
| 87040 | <1% | 1,134 | $10K | |
| 82948 | <1% | 2,324 | $10K | |
| 87899 | <1% | 694 | $9K | |
| 84466 | <1% | 1,020 | $8K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 97 | $8K |
| 86706 | <1% | 662 | $8K | |
| 86038 | <1% | 748 | $8K | |
| 85018 | <1% | 2,609 | $8K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 139 | $8K |
| 0012A | <1% | 215 | $8K | |
| 99223 | Prolong inpt eval add15 m | <1% | 132 | $7K |
| 86900 | <1% | 1,328 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,222 | $7K |
| 82247 | <1% | 356 | $6K | |
| 87045 | <1% | 685 | $6K | |
| 0011A | <1% | 215 | $6K | |
| 87015 | <1% | 651 | $6K | |
| 87634 | <1% | 124 | $6K | |
| 85652 | <1% | 2,472 | $6K | |
| 90686 | <1% | 2,355 | $6K | |
| 86704 | <1% | 424 | $6K | |
| 85730 | <1% | 1,684 | $6K | |
| 82550 | <1% | 1,347 | $6K | |
| 74018 | <1% | 322 | $5K | |
| 87205 | <1% | 1,042 | $5K | |
| 93971 | <1% | 207 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 365 | $5K |
| 85007 | <1% | 1,889 | $5K | |
| 87625 | <1% | 165 | $5K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 52 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 71 | $4K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 224 | $4K |
| 87400 | <1% | 253 | $4K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 219 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 28,799 | $4K |
| 82784 | <1% | 247 | $4K | |
| 72100 | <1% | 311 | $4K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 183 | $4K |
| 86592 | <1% | 542 | $3K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 101 | $3K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 53 | $3K |
| 95251 | <1% | 408 | $3K | |
| 73630 | <1% | 883 | $3K | |
| 73030 | <1% | 330 | $3K | |
| 94664 | <1% | 217 | $3K | |
| 90670 | <1% | 823 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $3K |
| 86901 | <1% | 1,312 | $3K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 138 | $3K |
| 97162 | <1% | 248 | $3K | |
| 93017 | <1% | 53 | $3K | |
| 84460 | <1% | 401 | $2K | |
| 73610 | <1% | 722 | $2K | |
| 87075 | <1% | 292 | $2K | |
| 86430 | <1% | 383 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,038 | $2K |
| 82248 | <1% | 483 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 66 | $2K |
| 82805 | <1% | 68 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 44 | $2K |
| 86709 | <1% | 215 | $2K | |
| 84146 | <1% | 105 | $2K | |
| 96367 | <1% | 44 | $2K | |
| 99335 | <1% | 241 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 32 | $2K |
| 87469 | <1% | 92 | $2K | |
| 87484 | <1% | 92 | $2K | |
| 87468 | <1% | 92 | $2K | |
| 12001 | <1% | 31 | $2K | |
| 85014 | <1% | 835 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 106 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 53 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,449 | $2K |
| 88304 | <1% | 179 | $2K | |
| A0425 | Ground mileage, per statute mile | <1% | 778 | $2K |
| 15275 | <1% | 59 | $2K | |
| 82803 | <1% | 120 | $2K | |
| 96368 | <1% | 23 | $2K | |
| 82565 | <1% | 189 | $1K | |
| 73110 | <1% | 167 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 44 | $1K |
| 20610 | <1% | 65 | $1K | |
| 90723 | <1% | 376 | $1K | |
| 86769 | <1% | 36 | $1K | |
| 73502 | <1% | 100 | $1K | |
| 87420 | <1% | 79 | $1K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 24 | $1K |
| 83615 | <1% | 258 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 639 | $1K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 484 | $1K |
| 90837 | Psychotherapy session, about an hour | <1% | 298 | $989.96 |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 15 | $988.18 |
| 90647 | <1% | 279 | $907.68 | |
| 73562 | <1% | 70 | $843.49 | |
| 99243 | <1% | 13 | $842.23 | |
| 86480 | <1% | 15 | $841.10 | |
| 94060 | <1% | 29 | $825.67 | |
| 86787 | <1% | 122 | $811.93 | |
| 83001 | <1% | 46 | $805.20 | |
| 90680 | <1% | 231 | $749.04 | |
| 84100 | <1% | 309 | $748.11 | |
| 96376 | <1% | 2,526 | $706.76 | |
| 87338 | <1% | 29 | $684.99 | |
| 92567 | <1% | 39 | $672.95 | |
| 73130 | <1% | 201 | $629.08 | |
| 84550 | <1% | 213 | $627.54 | |
| 85060 | <1% | 40 | $614.35 | |
| 99334 | <1% | 64 | $588.79 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 271 | $561.95 |
| 94726 | <1% | 43 | $561.42 | |
| 82105 | <1% | 40 | $523.52 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 15 | $447.89 |
| 36591 | <1% | 141 | $432.12 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $431.59 |
| 64615 | <1% | 14 | $430.29 | |
| 76536 | <1% | 15 | $418.39 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 31 | $414.12 |
| Q4133 | Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 342 | $366.39 |
| 82570 | <1% | 85 | $360.58 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 13 | $351.90 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 14 | $323.86 |
| 90715 | <1% | 82 | $320.42 | |
| 70486 | <1% | 18 | $313.23 | |
| 94729 | <1% | 29 | $310.83 | |
| 97161 | <1% | 44 | $308.63 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,900 | $305.13 |
| 90633 | <1% | 90 | $296.09 | |
| 99443 | <1% | 26 | $282.24 | |
| 94760 | <1% | 73 | $269.16 | |
| 88112 | <1% | 15 | $224.41 | |
| 97163 | <1% | 27 | $223.28 | |
| 17110 | <1% | 14 | $221.09 | |
| 85384 | <1% | 33 | $203.98 | |
| 82553 | <1% | 37 | $158.46 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 76 | $158.07 |
| 90700 | <1% | 45 | $147.89 | |
| 90685 | <1% | 46 | $145.83 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 124 | $136.34 |
| 90630 | <1% | 128 | $121.60 | |
| 84450 | <1% | 27 | $117.42 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,857 | $101.81 |
| 73564 | <1% | 283 | $99.21 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 499 | $93.86 |
| 82977 | <1% | 18 | $92.24 | |
| 90651 | <1% | 34 | $91.33 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,085 | $80.57 |
| 36592 | <1% | 55 | $68.38 | |
| 86308 | <1% | 14 | $67.93 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 62 | $55.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,554 | $50.82 |
| 90734 | <1% | 18 | $50.48 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 25 | $46.76 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,433 | $43.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,929 | $42.83 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 5,795 | $41.30 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 557 | $40.75 |
| 84156 | <1% | 16 | $38.05 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 29 | $36.80 |
| 96127 | <1% | 48 | $36.55 | |
| 74019 | <1% | 51 | $32.88 | |
| 36000 | <1% | 1,105 | $32.43 | |
| 81015 | <1% | 14 | $31.42 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,758 | $25.51 |
| A9270 | Non-covered item or service | <1% | 6,306 | $19.79 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 153 | $18.92 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,401 | $15.37 |
| 90656 | <1% | 40 | $15.25 | |
| 36416 | <1% | 792 | $9.18 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,147 | $8.31 |
| 69209 | <1% | 16 | $7.66 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,544 | $4.42 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,181 | $3.93 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 29 | $2.48 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,861 | $1.90 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 358 | $1.42 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 869 | $1.37 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,007 | $1.11 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 300 | $0.78 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 956 | $0.43 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 216 | $0.18 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,263 | $0.04 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 53 | $0.00 |
| D1110 | Prophylaxis - adult | 0% | 168 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 629 | $0.00 |
| D0220 | Intraoral - periapical first radiographic image | 0% | 84 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 29 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 32 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 169 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 124 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 409 | $0.00 |
| 90662 | 0% | 114 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 192 | $0.00 |
| G8990 | Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 57 | $0.00 |
| D0274 | Bitewings - four radiographic images | 0% | 68 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 50 | $0.00 |
| D2150 | Silver amalgam - two surfaces, primary or permanent | 0% | 87 | $0.00 |
| D1120 | Dental cleaning, child | 0% | 91 | $0.00 |
| D9110 | 0% | 22 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 31 | $0.00 |
| D2140 | 0% | 84 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 876 | $0.00 |
| D4355 | 0% | 16 | $0.00 | |
| D0210 | Intraoral - complete series of radiographic images | 0% | 71 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 796 | $0.00 |
| D0140 | Limited oral evaluation - problem focused | 0% | 99 | $0.00 |
| J3490 | Unclassified drugs | 0% | 335 | $0.00 |
| 90674 | 0% | 236 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 117 | $0.00 |
| A0434 | Specialty care transport (sct) | 0% | 76 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 284 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 76 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 30 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 398 | $0.00 |
| G8991 | Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 61 | $0.00 |
| D2160 | 0% | 21 | $0.00 | |
| 91301 | 0% | 423 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 71 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 21 | $0.00 |
| D2161 | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 158 | $0.00 |
| D2330 | 0% | 36 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 125 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 36 | $0.00 |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 0% | 13 | $0.00 |
| D2331 | 0% | 33 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 250 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 0% | 13 | $0.00 |
| D0272 | Bitewings - two radiographic images | 0% | 30 | $0.00 |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 60 | $0.00 |
| D2335 | 0% | 17 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 16 | $0.00 |
| D1351 | Sealant - per tooth | 0% | 169 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYANG, JERRY (SVP & CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.